RPHM
-
- (-%)
- · NASDAQ
- Sector -
- Industry -
- Website reneopharma.com
- Employees(FY) 55
- ISIN -
Performance
-
1W
-
1M
-
3M
-
6M
-
YTD
-
1Y
Profile
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases. Its lead product candidate is REN001, a potent and selective agonist of the peroxisome proliferator-activated receptor delta that is in clinical development for genetic mitochondrial diseases comprising primary mitochondrial myopathies and long-chain fatty acid oxidation disorders. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in Irvine, California.
Technical Analysis of RPHM 2024-10-07
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-10-06 16:32
OnKure and Reneo Pharmaceuticals complete merger(Yahoo Finance)
- 2024-10-04 04:57
- 2024-10-02 08:20
- 2024-08-12 19:35
- 2024-05-15 22:01
- 2024-05-12 20:25
- 2024-05-12 19:35
Reneo Pharmaceuticals and OnKure Announce Proposed Merger(Globenewswire)
- 2024-05-07 01:53
- 2024-05-06 19:35
- 2024-03-28 00:53
- 2024-03-27 19:35
- 2024-03-24 19:00
- 2023-12-21 03:13
These Stocks under $10 Are Poised To Explode(Yahoo Finance)
- 2023-12-14 21:19
- 2023-12-13 23:35
- 2023-12-13 20:05
- 2023-11-13 04:04
- 2023-11-12 18:35
- 2023-11-01 19:50
- 2023-10-24 19:50
- 2023-10-20 01:22
12 Best Performing Biotech Stocks in 2023(Yahoo Finance)
- 2023-10-08 19:50
- 2023-10-05 20:30
- 2023-08-28 19:35
- 2023-08-09 19:35
- 2023-08-09 19:31
- 2023-07-26 23:19
- 2023-06-29 20:25
- 2023-06-25 20:25
- 2023-06-15 00:44
Page 1 of 3
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.